Accordingly, we performed a cross-sectional analysis of a cohort of RA patients in order to determine whether CRP levels that are associated with high or very high cardiovascular risk are prevalent in patients whose articular disease is controlled. This evidence concerns the gene CRP and rheumatoid arthritis.